How to buy Merck & Co shares in 2025
Merck & Co. ($MRK) is a global pharmaceutical company focusing on the development and manufacture of prescription medicines, vaccines and health products for humans and animals.👉 Read on to learn about Merck & Co and how to buy $MRK shares in a few easy steps.
MRK
MRK
MRK
MRK
MRK
MRK
MRK
MRK
MRK
MRK
How to buy Merck & Co stock in 5 steps
When investing in shares - whether MRK or otherwise - it’s important to consider your financial position, investing goals and risk tolerance. Before making any investment decision, it’s wise to consider your current circumstances and consult with a financial planner or advisor. If you decide that investing in Merck & Co is right for you, then consider the following steps.
1. Open an investing account
To buy Merck & Co stock in Australia, you’ll need to sign up to an investing platform with access to the U.S. share market. Stake offers seamless access to 12,000+ stocks and ETFs across the U.S. and Australian markets, including MRK.
2. Fund your account
Once you’ve opened an account, you’ll need to deposit funds to allow you to buy MRK shares. With Stake, you can deposit via bank transfer, debit/credit card, Apple Pay, Google Pay or set up a recurring deposit using PayTo.
3. Search for Merck & Co or MRK
Find your prospective investment by searching the name or ticker symbol of the company. If you’re using Stake, you can easily search on our web trading platform or the Stake app.
4. Place an order for MRK shares
The next step is to place an order for the number of Merck & Co shares you’d like to buy. Be sure to check the market is open and ensure the order type and volume align with your investment plan.
5. Monitor your investment
Once your order executes, you should keep an eye on the company’s performance and monitor the performance of your portfolio. Check regularly to ensure your investment is aligned with your financial goals.
Put it on repeat?
If you intend to regularly purchase MRK shares, you could consider setting up a recurring investment. On Stake, you can set up a consistent purchase order for Merck & Co shares which may be useful if you’re thinking of investing in the company over the long term.
Merck & Co company overview
Merck & Co. is one of the largest pharmaceutical companies in the world, specialising in research, development and production of innovative medicines and vaccines. Founded in 1891, Merck's product portfolio covers a broad range of therapeutic areas including oncology, infectious diseases, diabetes and animal health. The company has a strong pipeline of new drugs and a commitment to developing treatments that address unmet medical needs. Merck’s vision is to save and improve lives around the world. It focuses on scientific excellence, innovative research and collaborations to deliver solutions to major health challenges.
Merck & Co share price performance
The Merck & Co share price was US$94.73 (-1.12%) as of market close.
Key metrics for Merck & Co
Get a breakdown of Merck & Co’s financial metrics.
| Latest market close | US$94.73 |
| Market capitalisation | US$239.29B |
| PE Ratio | 0.00 |
| Earnings per share | US$0.00 |
| Day change | -1.12% |
| 52-week high | US$134.63 |
| 52-week low | US$81.04 |
Data updated as of March 21, 2025.
Schedule a recurring investment in Merck & Co
Put your favourites on repeat - like Merck & Co - with a recurring investment on Stake. It’s a great way to build towards long-term goals and a convenient method to stay consistent with your investing habits.
You’re always in control, it’s easy to hit pause or skip a scheduled order.
Does Merck & Co pay dividends?
Yes, Merck & Co pays dividends.
| Dividend yield | 3.45% |
Data updated as of March 21, 2025.
What is the Merck & Co price target?
The average price target for MRK is US$108.17 across 6 combined analyst ratings.
The suggestion is to BUY with 50% of analysts suggesting to buy, 50% suggest hold and 0% suggest sell.
Analyst ratings and price targets are provided for informational purposes by our market data partner, Benzinga, and do not constitute a recommendation to make an investment decision. Future forecasts are not a reliable indicator of future performance.
How to sell Merck & Co shares?
The process of selling Merck & Co shares on Stake is similar to purchasing them. If you already own MRK shares on the platform and looking to sell, follow these steps:
- Open Stake, head to your Holdings and find Merck & Co
- Select Sell
- Choose the order type, number of shares/dollar value and the desired price (if applicable)
- Review your Sell order
- Follow the prompts to submit your order
Watch this video to see just how simple it is to buy and sell shares on Stake.
Is it a good time to buy Merck & Co shares?
Like any investment, Merck & Co may be a suitable option for some, but not for others. It’s important to understand that investing in any financial instrument comes with a certain level of risk.
You should always conduct your own research and consider your personal financial circumstances before buying $MRK shares. When researching, consider the company’s financial health, future prospects, current market conditions and whether or not it aligns with your investment strategy.
What are some similar stocks to MRK?
Pfizer Inc. ($PFE): Pfizer is a global pharmaceutical corporation that discovers, develops and manufactures healthcare products, including prescription drugs and vaccines, operating in many of the same therapeutic areas as Merck. Bristol Myers Squibb Co. ($BMY): Bristol Myers Squibb is a leading biopharmaceutical company focused on researching and developing treatments for oncology, cardiovascular disease and immunology, making it a strong peer to Merck in the pharmaceutical industry. Johnson & Johnson ($JNJ): Johnson & Johnson is a diversified healthcare giant, with a substantial pharmaceutical division developing a wide range of drugs and vaccines, along with a focus on consumer health and medical devices.
What are some ETFs that hold MRK?
Health Care Select Sector SPDR Fund ($XLV): This ETF tracks the performance of healthcare stocks in the S&P 500, with Merck being one of its top holdings, along with companies like Johnson & Johnson and UnitedHealth Group. Vanguard Health Care ETF ($VHT): VHT focuses on U.S. healthcare sector stocks, including pharmaceutical companies like Merck and also holds shares in other medical research, biotech and healthcare services firms. iShares U.S. Pharmaceuticals ETF ($IHE): This ETF targets the U.S. pharmaceuticals sector specifically, holding significant positions in Merck, Pfizer and other major pharmaceutical companies, providing exposure to the drug manufacturing industry.
Why invest on Stake?
Join 500k+ ambitious investors on a powerful yet easy-to-use trading platform.
Invest in Merck & Co for as little as US$10
Own a slice of the world’s biggest stocks like Merck & Co, investing as little as US$10.
12,000+ global opportunities
Hold AUD and USD and glide between Aussie and U.S. markets with just a tap.
Simple fees
$3 brokerage on all trades up to $30,000, whether it’s Wall St or the ASX.
Extended Hours on Wall St
An additional 9.5 hours of Wall St access per trading day, so you can react faster.
Merck & Co Common Questions
- Sign up to Stake on desktop or via the Stake app
- Activate Stake wall-st
- Deposit funds via bank transfer, credit/debit card, Apple Pay/Google Pay or PayTo
- Place a buy order for Merck & Co
- Monitor your investment
Fractional shares allow U.S. investors to purchase a portion of a share in lieu of an entire stock. This can be advantageous for some investors who seek to hold a company in their portfolio but don’t want to pay for a full share.
So, in the case of Merck & Co, you could buy in with as little as US$10 instead of paying for a full share which was valued at US$93.67 at last market close.
Take control of your financial future
This is for information purposes only and is not a recommendation to invest in the securities listed. Such information is not intended to constitute financial advice and no agency or advisory relationship is created between you and Stake as a result of having access to or using the Information. This information does not take into account your personal objectives, financial situation or needs. You agree that neither Stake nor any third party provider is responsible for any investment decisions or for any damages or other losses resulting from the use of the Information. As always, do your own research before making any investment decisions and consider seeking advice from a licensed financial adviser. No representation or warranty is made as to the timeliness, reliability, accuracy or completeness of the material and Stake does not accept any responsibility arising from errors in, or omissions from, the data. Past performance is not a reliable indicator of future performance.